Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells.
Ontology highlight
ABSTRACT: CD19-directed CAR-T-cells (CD19-CAR) have demonstrated remarkable clinical results in patients suffering from refractory or relapsed lymphoma and acute lymphoblastic leukemia. In order to further optimize follow-up, to explain treatment failure, and to control adverse events biomarkers for monitoring of response are urgently needed. Peak expansion and persistence are correlated with response rates and severity of side effects. However, no standardized method or commercially assay for CD19-CAR measurement is established yet. In this study, two primer-probe assays for digital-droplet PCR (ddPCR) were designed and subsequently explored on 54 samples collected from seven patients after CD19-CAR treatment with axi-cel over time. Detection and quantification of CAR-T-cells were feasible and reli
SUBMITTER: Mika T
PROVIDER: S-EPMC7243121 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA